This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Cytodigm, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Nicholas Boylan
Introduction: Nicholas Boylan is an inventor based in Baltimore, MD (US), affiliated with Johns Hopkins University. He is known for his work in developing innovative nanoparticle technologies aimed at enhancing mucosal penetration and decreasing inflammation. Although he currently holds no granted patents, his research contributions are noteworthy.
Latest Patent Applications: One of his significant patent applications is titled "Nanoparticles with Enhanced Mucosal Penetration or Decreased Inflammation." This application describes nanoparticles formed by an emulsion of core polymers, surface-altering materials, and low molecular weight emulsifiers. The process involves dissolving core polymers in an organic solvent and creating an emulsion with an aqueous solution of emulsifiers. The preferred embodiment specifies that the molecular weight of the emulsifiers is less than 1500 amu, with examples including cholic acid sodium salt and TWEEN® 20. The application highlights the importance of achieving a neutral surface charge for the nanoparticles, which is crucial for their effectiveness.
Conclusion: Nicholas Boylan's innovative work at Johns Hopkins University showcases his commitment to advancing nanoparticle technology, despite not having any granted patents at this time. His research has the potential to significantly impact medical applications in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile